Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection.
Open Access
- 1 April 1996
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 97 (7) , 1655-1665
- https://doi.org/10.1172/jci118592
Abstract
Clearance of the hepatitis B virus (HBV) during acute hepatitis is associated with a strong, polyclonal, multispecific cytotoxic T lymphocyte (CTL) response to the viral envelope, nucleocapsid and polymerase proteins that persists for decades after clinical recovery. In contrast, chronically infected patients usually fail to mount a strong CTL response to this virus. In this study we demonstrate that chronically infected patients who experience a spontaneous or interferon-induced remission develop a CTL response to HBV that is similar in strength and specificity to patients who have recovered from acute hepatitis. The results suggest that specific immunotherapeutic enhancement of the CTL response to HBV should be possible in chronically infected patients, and that it could lead to viral clearance in these individuals with resolution of chronic liver disease.Keywords
This publication has 23 references indexed in Scilit:
- Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans.Journal of Clinical Investigation, 1995
- Hepatitis B virus persistence after recovery from acute viral hepatitis.Journal of Clinical Investigation, 1994
- A randomized, controlled trial of recombinant alpha-interferon therapy for chronic hepatitis B.1993
- HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection.The Journal of Immunology, 1993
- HLA-A31- and HLA-Aw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis.The Journal of Experimental Medicine, 1993
- Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion.Journal of Clinical Investigation, 1992
- HLA class I-restricted human cytotoxic T cells recognize endogenously synthesized hepatitis B virus nucleocapsid antigen.Proceedings of the National Academy of Sciences, 1991
- Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen.The Journal of Experimental Medicine, 1991
- Long-Term Remission of Chronic Hepatitis B after Alpha-Interferon TherapyAnnals of Internal Medicine, 1991
- Recognition of hepatitis B virus envelope proteins by liver-infiltrating T lymphocytes in chronic HBV infection.The Journal of Immunology, 1989